Company intelligence / Profile preview

Sichuan Bailong Biotechnology

Ownership: Private
Development stage: Other

Overview

Sichuan Bailong Biotechnology is one of China’s largest manufacturers and exporters of ferrous sulfate products, primarily Ferrous Sulphate Monohydrate. The company operates as a subsidiary of LB Group and serves global markets with industrial chemical products used across agriculture, animal feed, water treatment, mining, and some pharmaceutical applications as raw materials—not finished drugs or therapies. It does not have a clinical pipeline or drug development activities.

Industry: Chemicals & Materials

Partnerships

CargillNew Hope GroupTongwei GroupTwins GroupLafarge GroupCRHFerro Duo

Beyond the preview

Go deeper on Sichuan Bailong Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sichuan Bailong Biotechnology.

Explore the full profile